SG11201507667SA - Fine dry particulate retinoid active agent compositions and topical formulations including the same - Google Patents

Fine dry particulate retinoid active agent compositions and topical formulations including the same

Info

Publication number
SG11201507667SA
SG11201507667SA SG11201507667SA SG11201507667SA SG11201507667SA SG 11201507667S A SG11201507667S A SG 11201507667SA SG 11201507667S A SG11201507667S A SG 11201507667SA SG 11201507667S A SG11201507667S A SG 11201507667SA SG 11201507667S A SG11201507667S A SG 11201507667SA
Authority
SG
Singapore
Prior art keywords
active agent
same
topical formulations
agent compositions
formulations including
Prior art date
Application number
SG11201507667SA
Inventor
Zahra Mansouri
Xin Chen
Rodica-Tatiana Canelide
Original Assignee
Lab Skin Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201507667S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lab Skin Care Inc filed Critical Lab Skin Care Inc
Publication of SG11201507667SA publication Critical patent/SG11201507667SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
SG11201507667SA 2013-03-15 2014-03-14 Fine dry particulate retinoid active agent compositions and topical formulations including the same SG11201507667SA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798758P 2013-03-15 2013-03-15
US201461938080P 2014-02-10 2014-02-10
PCT/US2014/029673 WO2014145034A1 (en) 2013-03-15 2014-03-14 Fine dry particulate retinoid active agent compositions and topical formulations including the same

Publications (1)

Publication Number Publication Date
SG11201507667SA true SG11201507667SA (en) 2015-10-29

Family

ID=51528082

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201507667SA SG11201507667SA (en) 2013-03-15 2014-03-14 Fine dry particulate retinoid active agent compositions and topical formulations including the same

Country Status (16)

Country Link
US (5) US20140271879A1 (en)
EP (1) EP2968157B1 (en)
JP (1) JP2016514694A (en)
KR (1) KR20150131285A (en)
CN (2) CN105358135A (en)
AU (1) AU2014233420A1 (en)
BR (1) BR112015023117A2 (en)
CA (1) CA2906838A1 (en)
CL (1) CL2015002688A1 (en)
EA (1) EA201591826A1 (en)
ES (1) ES2975482T3 (en)
MX (1) MX366277B (en)
MY (1) MY183106A (en)
NZ (1) NZ713342A (en)
SG (1) SG11201507667SA (en)
WO (1) WO2014145034A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201903125QA (en) * 2008-09-23 2019-05-30 Laboratory Skin Care Inc Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
BR112015023117A2 (en) * 2013-03-15 2017-07-18 Laboratory Skin Care Inc dry fine particulate retinoid active agent compositions and topical formulations including the same
JP2018501298A (en) * 2014-11-03 2018-01-18 ステラ アンド ドット エルエルシー Skin care formulations and regimens
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
CN113181073B (en) * 2021-04-30 2022-12-23 广州市科能化妆品科研有限公司 Composite vitamin emulsion, wrinkle-removing essence cream and preparation method thereof
WO2024045049A1 (en) * 2022-08-31 2024-03-07 L'oreal Composition for caring for keratin materials and mask containing the same
CN115820338A (en) * 2023-02-22 2023-03-21 中国科学院昆明植物研究所 Preparation method and application of deodorized prinsepia utilis royle oil

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559149A (en) * 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
FR2717686B1 (en) * 1994-03-22 1996-06-28 Fabre Pierre Cosmetique Dermo-cosmetic composition and preparation process.
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US5851538A (en) * 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
FR2774907B1 (en) * 1998-02-19 2000-05-12 Luc Dewandre NEW TOPICAL FORMULATION BASED ON RETINALDEHYDE
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
DE10233740A1 (en) * 2002-07-24 2004-02-05 Basf Ag Preparations containing retinoids
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
EP1674093A4 (en) * 2003-10-15 2009-12-09 Nanoegg Res Lab Inc Method of controlling particle size of retinoic acid nanoparticles coated with polyvalent metal inorganic salt and nanoparticles obtained by the controlling method
US20100330014A1 (en) * 2008-01-30 2010-12-30 Tbc Group Co., Ltd. Composition for external application on skin, and skin-whitening cosmetic
SG10201903125QA (en) * 2008-09-23 2019-05-30 Laboratory Skin Care Inc Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
WO2010050980A1 (en) 2008-10-31 2010-05-06 Laboratory Skin Care, Inc. Topical formulations comprising hydroxyapatite particles for stimulation and maintenance of collagen fibers
JP2012526144A (en) * 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド Transdermal delivery composition comprising active substance-calcium phosphate particle complex and method of use thereof
WO2011060099A2 (en) * 2009-11-10 2011-05-19 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles, and methods of making and using the same
BR112015023117A2 (en) * 2013-03-15 2017-07-18 Laboratory Skin Care Inc dry fine particulate retinoid active agent compositions and topical formulations including the same
WO2019068096A1 (en) * 2017-09-29 2019-04-04 Rodan & Fields, Llc Retinaldehyde containing compositions and methods of use

Also Published As

Publication number Publication date
EP2968157A1 (en) 2016-01-20
AU2014233420A1 (en) 2015-11-12
US20180028469A1 (en) 2018-02-01
WO2014145034A1 (en) 2014-09-18
CL2015002688A1 (en) 2016-04-08
US20140271879A1 (en) 2014-09-18
NZ713342A (en) 2020-12-18
CN112263549A (en) 2021-01-26
JP2016514694A (en) 2016-05-23
BR112015023117A2 (en) 2017-07-18
MX366277B (en) 2019-07-04
EA201591826A1 (en) 2016-01-29
ES2975482T3 (en) 2024-07-08
MY183106A (en) 2021-02-15
EP2968157B1 (en) 2023-11-08
US20200222336A1 (en) 2020-07-16
CA2906838A1 (en) 2014-09-18
KR20150131285A (en) 2015-11-24
US20160317469A1 (en) 2016-11-03
AU2014233420A8 (en) 2015-11-26
EP2968157A4 (en) 2016-12-14
CN105358135A (en) 2016-02-24
US20210259991A1 (en) 2021-08-26
MX2015013254A (en) 2016-04-15

Similar Documents

Publication Publication Date Title
ZA201602510B (en) Strigolactone formulations and uses thereof
IL263978B (en) Amorphous letermovir and solid pharmaceutical formulations comprising same and uses thereof
EP3043824A4 (en) Modified therapeutic agents and compositions thereof
RU2016118771A3 (en) Co-crystals and pharmaceutical compositions comprising the same
SG11201507667SA (en) Fine dry particulate retinoid active agent compositions and topical formulations including the same
HK1217651A1 (en) Solid solution compositions and use in severe pain
EP2961382A4 (en) Topical compositions and methods of using the same
GB2569249C (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents and uses thereof
EP3030266A4 (en) Topical compositions and methods of using the same
EP3054937A4 (en) Spray dry formulations
EP2968107A4 (en) Cosmetic compositions and uses thereof
PL3068437T3 (en) Sprayable topical carrier and composition comprising phosphatidylcholine
EP2976091C0 (en) Antioxidatively active composition and the use thereof
IL246167A0 (en) Berberine formulations and uses thereof
HK1213813A1 (en) Icotinib-containing topical skin pharmaceutical compositions and uses thereof
IL240867B (en) Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
EP3057440A4 (en) Formulation preventing necrotic enteritis in galloanserans
IL242711B (en) Agomelatine formulations comprising agomelatine in the form of co-crystals
SG11201507651XA (en) Fine dry particulate resveratrol active agent compositions and topical formulations including the same
ZA201403974B (en) Fine dry particulate adenosine compositions and topical formulations including the same
AP2016009305A0 (en) Insecticide compound and the compositions thereof
EP3007813A4 (en) Phosphate ester dispersion promoting agent and dispersion comprising the same
AU2013902944A0 (en) Detergent compositions and their use
TH1401006437A (en) Topical spray composition and system for delivering the same.